LPA and metabolic syndrome: It’s worth clarifying that Lp(a) dyslipidemia is in reality, the most widespread form of monogenic dyslipidemia, affecting nearly 1 in 5 individuals in the United States when Lp(a) levels exceed 50 mg/dL [13].